Literature DB >> 7569994

Transfer of genes to humans: early lessons and obstacles to success.

R G Crystal1.   

Abstract

Enough information has been gained from clinical trials to allow the conclusion that human gene transfer is feasible, can evoke biologic responses that are relevant to human disease, and can provide important insights into human biology. Adverse events have been uncommon and have been related to the gene delivery strategies, not to the genetic material being transferred. Human gene transfer still faces significant hurdles before it becomes an established therapeutic strategy. However, its accomplishments to date are impressive, and the logic of the potential usefulness of this clinical paradigm continues to be compelling.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569994     DOI: 10.1126/science.270.5235.404

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  129 in total

1.  Frequency and stability of chromosomal integration of adenovirus vectors.

Authors:  A Harui; S Suzuki; S Kochanek; K Mitani
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Bad for cats, good for humans? Modified feline immunodeficiency virus for gene therapy.

Authors:  R G Crystal
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

4.  Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.

Authors:  C Hofmann; P Löser; G Cichon; W Arnold; G W Both; M Strauss
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Passive entry of a DNA molecule into a small pore.

Authors:  P G de Gennes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Gene therapy for cardiovascular diseases.

Authors:  E G Nabel
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

7.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

Authors:  C Hidaka; E Milano; P L Leopold; J M Bergelson; N R Hackett; R W Finberg; T J Wickham; I Kovesdi; P Roelvink; R G Crystal
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

8.  Direct visualization at the single-cell level of electrically mediated gene delivery.

Authors:  Muriel Golzio; Justin Teissie; Marie-Pierre Rols
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

9.  Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity.

Authors:  Andrei N Varnavski; Yi Zhang; Michael Schnell; John Tazelaar; Jean-Pierre Louboutin; Qian-Chun Yu; Adam Bagg; Guang-ping Gao; James M Wilson
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  The 17 nucleotides downstream from the env gene stop codon are important for murine leukemia virus packaging.

Authors:  S S Yu; J M Kim; S Kim
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.